Servicio de Urgencias, Hospìtal del Mar, Barcelona, España. Unitat Funcional de Toxicología del Parc de Salut Mar, Barcelona, España. Grup de Treball de Toxicologia de la SoCMUE (SoCMUETox), España. Fundación Española de Toxicología Clínica, España.
Complexo Hospitalario Universitario de Vigo, Hospital Álvaro Cunqueiro, Vigo, España.
Emergencias. 2023 Oct;35(5):328-334. doi: 10.55633/s3me/E023.2023.
Digoxin toxicity accounts for a small percentage of poisonings attended by emergency departments. This study aimed to describe differences between acute and chronic digoxin toxicity and assess the use of digoxin-specific antibody fragments (digoxin-Fab) as an antidote.
Retrospective, observational, multicenter study in 15 hospital emergency departments in 8 Spanish autonomous communities in 7 years. We collected patient, clinical and treatment variables, and discharge destination. Patients were classified according to whether toxicity was acute or chronic and whether digoxin-Fab was administered or not.
Twenty-seven acute and 631 chronic digoxin poisonings were attended. The mean (SD) patient age was 83.9 (7.9) years, and 76.9% were women. Patients with acute toxicity were younger (80.0 [12] years) than those with chronic toxicity (84.1 [7.7] years) (P .038), and accidental poisoning was less common (in 85.2% vs 100% in chronic toxicity; P .001). Cases of acute toxicity were also more serious (Poison Severity Score (29.6% vs 12.5% in chronic toxicity; P .001). Thirty-four patients were treated with digoxin-Fab (5.4%). These patients were younger (78.7 [11.5] years vs 84.2 (7.6) years), their toxicity was more often acute (in 20.6% vs 3.2% in chronic toxicity), more had attempted suicide (8.8% vs 0.2% with chronic toxicity), and more had severe symptoms (50% vs 11.2%) (P .001, all comparisons). Hospital admission was required for 76.1%. Overall, mortality was 11.4%.
Chronic toxicity accounts for most digoxin poisoning cases, and most patients are women. Acute toxicity is more serious. Patients who required digoxin-Fab have more severe poisoning. Such patients usually have acute toxicity, and attempted suicide is more often the reason for the emergency.
地高辛中毒在急诊科就诊的中毒患者中占比较小。本研究旨在描述急性和慢性地高辛中毒之间的差异,并评估地高辛特异性抗体片段(地高辛-Fab)作为解毒剂的应用。
这是一项在西班牙 8 个自治区的 15 家医院急诊科进行的回顾性、观察性、多中心研究,共 7 年时间。我们收集了患者、临床和治疗变量以及出院去向。根据毒性是急性还是慢性以及是否使用地高辛-Fab 进行了分类。
共收治 27 例急性地高辛中毒和 631 例慢性地高辛中毒患者。患者的平均(SD)年龄为 83.9(7.9)岁,76.9%为女性。急性中毒患者较慢性中毒患者年轻(80.0[12]岁 vs 84.1[7.7]岁)(P.038),意外中毒较不常见(分别为 85.2%和 100%)(P.001)。急性中毒病例也更为严重(中毒严重程度评分[29.6% vs 慢性中毒[12.5%];P.001)。34 例患者接受了地高辛-Fab 治疗(5.4%)。这些患者更年轻(78.7[11.5]岁 vs 84.2(7.6)岁),其毒性更常为急性(分别为 20.6%和 3.2%),更有自杀企图(分别为 8.8%和 0.2%),且症状更严重(分别为 50%和 11.2%)(P.001,所有比较)。需要住院治疗的有 76.1%。总体死亡率为 11.4%。
慢性中毒占地高辛中毒病例的大多数,且大多数患者为女性。急性中毒更严重。需要地高辛-Fab 的患者中毒更严重。这些患者通常患有急性中毒,且自杀企图更常见于紧急情况。